Blood Based Articles & Analysis: Older
14 articles found
The diagnostic biomarker services at Alfa Cytology are tailored for accuracy and practicality, ensuring comprehensive support in various research endeavors. These include the discovery of blood-based biomarker and tissue biomarker, among others. Alfa Cytology’s team excels at designing innovative diagnostic programs and performing rigorous validation studies to ...
Dr. Kate Sasser from Tempus led a discussion on the potential of antibody-drug conjugates (ADCs), their challenges in targeting tumor antigens, and the future of cancer treatment with Dr. Daniel Johnson, Dr. Funda Meric-Bernstam, and Dr. Kellogg Parsons. The oncology field is rapidly advancing with the development of antibody-drug conjugates (ADCs), offering new hope for ...
ByTempus
The remote blood collection technology needed to be easy for subjects to use, quick to deploy, and produce a stable clinical-grade sample. Further, overall user experience needed to be positive in order to encourage completion of the multiple blood collection timepoints required. “The nature of the studies we are performing—which involve multiple ...
INOVIQ Ltd (ASX:IIQ) has successfully completed a feasibility study to evaluate the use of SubB2M as an immunohistochemistry (tissue-based test) reagent to aid in discriminating between benign skin lesions, malignant and metastatic melanoma. ...
PREVECOLl® is an AMADIX’ blood-based test for colorectal cancer detection. Read the full new here ...
ByAmadix
I then completed my honours thesis at UNSW with Regeneus, focusing on blood-based assays to increase the detection sensitivity of the stem cell secretome. ...
Abstract Messenger RNA (mRNA) based vaccines (Pfizer/BioNTech and Moderna) are highly effective at providing immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). ...
A study of Universal Diagnostics' blood-based colorectal cancer test found it was more than 90 percent accurate, the company announced June 3. The blood test was found to detect colorectal cancer with 92 percent sensitivity and 97 percent specificity. ...
SEVILLE, Spain--(BUSINESS WIRE)--Universal Diagnostics (UDX), an in-vitro diagnostics company developing minimally-invasive, blood-based solutions for detecting cancer early, announced today that it has started a prospective, multi-center observational study in the US for its investigational advanced adenoma (precursor lesions) and colorectal cancer (CRC) ...
Instead of a mechanical device where an action is taken to collect the blood, this device uses the patient’s blood pressure to fill a side channel with the initial blood and contaminants that are often in that skin plug. When a vacuum source, like a blood culture bottle, is attached, the blood from the vein ...
A team of scientists at the University of California, Berkeley developed a wearable sensor to monitor an individual’s health based upon their sweat. The sensor is constructed as a patch with a spiral-patterned microfluidic component where sweat samples can flow and be analyzed.[1] It has shown potential for monitoring sodium and fluid loss, and in some cases potassium.[1] ...
Following a successful fundraising in Q4 2016, METAFORA achieves an important milestone by announcing, in partnership with CERBA Healthcare, the availability of the METAglut1 blood test to diagnose the GLUT1 deficiency syndrome (GLUT1 DS). Through METAglut1, our disruptive technology becomes available, for the first time, to patients. ...
We evaluated a novel, magnetic-bead-based histo-blood group antigen assay for the recovery of low numbers of norovirus particles. ...
In this paper, we present data from exposed human patients, showing that a simple assay using blood can demonstrate variation in the extent and type of non-targeted effects and that exposure to radiation can modulate the subsequent non-targeted response to a later dose. Patients undergoing radiotherapy treatment for cancer gave blood samples immediately after the ...